Secaucus, New Jersey — Hudson Regional Hospital proudly announces its acquisition of the highly advanced da Vinci Xi surgical robot, building towards its promise of providing the residents of Secaucus and its neighboring communities with a sophisticated, modern facility that provides cutting edge, high-quality healthcare services to its patients.
Hudson Regional Hospital’s procurement of the da Vinci XI robotic surgical system – which follows its recent acquisition of the Mazor Robotics Renaissance Surgical Guidance System – is the most recent example of the hospital’s new ownership’s commitment towards investing in advanced technologies that will greatly benefit the community. These minimally invasive treatment options can drastically improve the quality of life for patients with significantly reduced recovery time.
“As the role of technology in modern medical care grows larger every year, we believe there is substantial opportunity to expand robotic usage across all our practice areas,” said Dr. Nizar Kifaieh, President and CEO of Hudson Regional Hospital. “As such, we continuously assess available or emerging technologies, such as the multi-limbed da Vinci system that enables our surgeons to perform better – and with minimal invasion – therefore benefitting our surgical teams and ultimately, our patients. Our goal is to put the right technology in the hands of our capable and skilled surgeons to provide patients with the best possible clinical outcome.”
Considered one of the most dynamic tools for robotic surgery in the world, the da Vinci robotic surgery system delivers a high degree of fidelity and precision in the control of surgical instruments. Operated by a trained surgeon – who is in full control throughout the procedure – utilizing dedicated equipment, the system improves comfort for both surgeons and patients alike.
“We can now provide a minimally invasive surgical approach for a wide range of patients and surgical complexities,” said Dr. Yitzhack Asulin, Hudson Regional Hospital’s female pelvis reconstructive and robotic surgery director. “Gone are the days of a long painful recovery from an open traditional hysterectomy or myomectomy; our patients now can take advantage of this state of the art robotic surgery system and undergo the most complex pelvic surgeries which require only a couple tiny incisions that are only 1/3 of an inch in size.”
Dr. Asulin continued, “The techniques available with the da Vinci robotic surgical system result in significantly reduced post-operative pain, very small incisions, little to no blood loss, much quicker recovery, and a significantly less aggressive opioid pain medication regimen – an important consideration. We can typically send patients home the same day or the morning following a procedure.”
In addition to gynecological procedures, the da Vinci robotic surgical system will provide minimally invasive surgical options for patients who have prostate cancer, herniation, bariatric surgery, and general surgery.
‘”Led by a ‘patient-first’ philosophy, it is Hudson Regional Hospital’s mission to provide superior and compassionate care no matter what brings them to our hospital,” said Yan Moshe, Chairman of the Board. “Acquisitions such as the da Vinci XI surgical robot reflect our commitment to improving the overall patient experience while working to solidify the medical center’s reputation as a leader in the advancements of medicine, facilitator of exceptional care and trusted resource for the Northern Jersey communities we serve.”
About Hudson Regional Hospital
Hudson Regional Hospital (HRH) is an acute care, 200-bed hospital, located between the shores of the Hackensack River and overlooking the Meadowlands and NYC skyline. Since the start of 2018, the hospital’s new ownership group has made significant investments towards solidifying its place as a leader in the advancement of medicine and delivery of an exceptional, cost-effective healthcare experience to its patients.
For more information on the new Hudson Regional Hospital please visit www.HudsonRegionalHospital.com
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. (Nasdaq:ISRG), headquartered in Sunnyvale, Calif., is the global leader in robotic-assisted, minimally invasive surgery. Intuitive Surgical develops, manufactures and markets the da Vinci® Surgical System. Intuitive Surgical’s mission is to extend the benefits of minimally invasive surgery to those patients who can and should benefit from it.
About the da Vinci Surgical System
The da Vinci Surgical System is a surgical platform designed to enable complex surgery using a minimally invasive approach. The da Vinci Surgical System consists of an ergonomic surgeon console or consoles, a patient-side cart with three or four interactive arms, a high-performance vision system and proprietary EndoWrist® instruments. Powered by state-of-the-art technology, the da Vinci Surgical System is designed to scale, filter and seamlessly translate the surgeon’s hand movements into more precise movements of the EndoWrist instruments. The net result is an intuitive interface with advanced surgical capabilities. By providing surgeons with superior visualization, enhanced dexterity, greater precision and ergonomic comfort compared to other surgical approaches, the da Vinci Surgical System makes it possible for skilled surgeons to perform minimally invasive procedures involving complex dissection or reconstruction.
All surgery presents risk, including da Vinci Surgery and other minimally invasive procedures. Serious complications may occur in any surgery, up to and including death. Examples of serious and life-threatening complications, which may require hospitalization, include injury to tissues or organs, bleeding, infection, and internal scarring that can cause long-lasting dysfunction or pain. For more complete information on risks, considerations, safety, and indications for use, please refer to www.davincisurgery.com. For more information about clinical evidence related to da Vinci Surgery, please visit www.intuitivesurgical.com/company/clinical-evidence/.